In this study containing 43 BRAF mutant colon cancer, the expression of CD8+ T cells was found to be significantly higher in BRAF mutant colon cancer patients than in wild-type ones (P < 0.001) [85]. This evidence concerns the gene BRAF and malignant colon neoplasm.